NeuroMetrix, Inc. Warrants
NUROW
NUROW was delisted on the 26th of May, 2020.
2 hedge funds and large institutions have $1K invested in NeuroMetrix, Inc. Warrants in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$156 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$27 |
NUROW Hedge Fund Activity: Q1 2019 in Review
2 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Warrants (NUROW) for Q1 2019, worth a combined $1K.
Fund positioning in NUROW was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $156.
- 2 institutional investors held NeuroMetrix, Inc. Warrants (NUROW) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $1K of NeuroMetrix, Inc. Warrants stock for Q1 2019.
- 0 funds opened new NeuroMetrix, Inc. Warrants positions in Q1 2019 and 0 closed out.
- The largest NeuroMetrix, Inc. Warrants seller in Q1 2019 was Susquehanna International Group, an estimated $156 sold.
Based on aggregated 13F filings for Q1 2019.